Skip to main content

Main menu

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Other Publications
    • cbm

User menu

  • My alerts

Search

  • Advanced search
Cancer Biology & Medicine
  • Other Publications
    • cbm
  • My alerts
Cancer Biology & Medicine

Advanced Search

 

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Follow cbm on Twitter
  • Visit cbm on Facebook
Research ArticleOriginal Article

LncRNA HIF1A-AS2 accelerates malignant phenotypes of renal carcinoma by modulating miR-30a-5p/SOX4 axis as a ceRNA

Mingwei Chen, Xuedong Wei, Xiu Shi, Le Lu, Guangbo Zhang, Yuhua Huang and Jianquan Hou
Cancer Biology & Medicine May 2021, 18 (2) 587-603; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0209
Mingwei Chen
1Department of Urology, The First Affiliated Hospital of Soochow University, Suzhou 215006, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xuedong Wei
1Department of Urology, The First Affiliated Hospital of Soochow University, Suzhou 215006, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xiu Shi
2Department of Obstetrics and Gynecology, The First Affiliated Hospital of Soochow University, Suzhou 215006, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Le Lu
1Department of Urology, The First Affiliated Hospital of Soochow University, Suzhou 215006, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Guangbo Zhang
1Department of Urology, The First Affiliated Hospital of Soochow University, Suzhou 215006, China
3Jiangsu Institute of Clinical Immunology, The First Affiliated Hospital of Soochow University, Jiangsu Key Laboratory of Clinical Immunology, Soochow University, Jiangsu Key Laboratory of Gastrointestinal Tumor Immunology, Suzhou 215006, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yuhua Huang
1Department of Urology, The First Affiliated Hospital of Soochow University, Suzhou 215006, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jianquan Hou
1Department of Urology, The First Affiliated Hospital of Soochow University, Suzhou 215006, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jianquan Hou
  • For correspondence: xf_192{at}163.com
  • Article
  • Figures & Data
  • Info & Metrics
  • References
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Supplementary Materials
  • The relative expressions of HIF1A-AS2 and miR-30a-5p in renal carcinoma patients’ samples and cells. Samples were detected, and the distribution of HIF1A-AS2 was mainly in the cytoplasm. GAPDH was the internal control gene. The relative expression patterns of HIF1A-AS2 (A and B) and miR-30a-5p (C and D) are shown in paired kidney carcinoma tissues and normal tissues. We also compared their expression levels in renal carcinoma cells (786-O, ACHN, and OS-RC-2 cells) and 293T cells (F-H). The distribution of HIF1A-AS2 was analyzed by fluorescence in situ hybridization in 786-O, ACHN and OS-RC-2, and 293T cells [I (a-d)]. The18S RNA and U6 indicated cytoplasm and nucleus, respectively. (*P
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1

    The relative expressions of HIF1A-AS2 and miR-30a-5p in renal carcinoma patients’ samples and cells. Samples were detected, and the distribution of HIF1A-AS2 was mainly in the cytoplasm. GAPDH was the internal control gene. The relative expression patterns of HIF1A-AS2 (A and B) and miR-30a-5p (C and D) are shown in paired kidney carcinoma tissues and normal tissues. We also compared their expression levels in renal carcinoma cells (786-O, ACHN, and OS-RC-2 cells) and 293T cells (F-H). The distribution of HIF1A-AS2 was analyzed by fluorescence in situ hybridization in 786-O, ACHN and OS-RC-2, and 293T cells [I (a-d)]. The18S RNA and U6 indicated cytoplasm and nucleus, respectively. (*P < 0.05; **P < 0.01).

  • Knockdown or overexpression of HIF1A-AS2 suppressed or promoted cell progression. The relative expression level of HIF1A-AS2 was significantly downregulated by si-HIF1A-AS2 (A) and pcDNA3.1-HIF1A-AS2 (B). Analysis of variance was used for the comparison of curves of cell proliferation. Cell proliferation was detected in both renal carcinoma cells after transfection of si-RNA [C (a-c)] and pcDNA3.1-HIF1A-AS2 [C (d)]. Representative images of EdU assays and the relative fold changes of EdU positive cells were detected by si-RNA [D (a–c)] and pcDNA3.1-HIF1A-AS2 [D (d)]. The relative cell migration was suppressed after transfection of si-RNA, and the representative images were as follow [E (a–c)]. The relative cell migration was promoted after transfection of pcDNA3.1-HIF1A-AS2, and the representative images are shown in [E (d)]. Apoptotic cells were measured after transfection of si-RNA [F (a–c)] and pcDNA3.1 [F (d)] by flow cytometry analyses. (*P
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2

    Knockdown or overexpression of HIF1A-AS2 suppressed or promoted cell progression. The relative expression level of HIF1A-AS2 was significantly downregulated by si-HIF1A-AS2 (A) and pcDNA3.1-HIF1A-AS2 (B). Analysis of variance was used for the comparison of curves of cell proliferation. Cell proliferation was detected in both renal carcinoma cells after transfection of si-RNA [C (a-c)] and pcDNA3.1-HIF1A-AS2 [C (d)]. Representative images of EdU assays and the relative fold changes of EdU positive cells were detected by si-RNA [D (a–c)] and pcDNA3.1-HIF1A-AS2 [D (d)]. The relative cell migration was suppressed after transfection of si-RNA, and the representative images were as follow [E (a–c)]. The relative cell migration was promoted after transfection of pcDNA3.1-HIF1A-AS2, and the representative images are shown in [E (d)]. Apoptotic cells were measured after transfection of si-RNA [F (a–c)] and pcDNA3.1 [F (d)] by flow cytometry analyses. (*P < 0.05; **P < 0.01).

  • The miR-30a-5p acted as an anti-oncogene. The relative expression level of miR-30a-5p was significantly downregulated by the miR-30a-5p inhibitor and increased by miR-30a-5p mimics (A). We detected cell proliferation after miR-30a-5p inhibitor and miR-30a-5p mimic transfection [B (a-c)] in renal carcinomas cells. Representative images of EdU assays and the relative fold changes of EdU positive cells were detected by the miR-30a-5p inhibitor and miR-30a-5p mimics [C (a–c)]. The relative cell migration was inhibited or accelerated after miR-30a-5p mimics or inhibitor transfection in renal cancer [D (a–c)] cell lines. Flow cytometry analysis was used to measured apoptotic cells after miR-30a-5p mimics or inhibitor transfection in the renal cancer [E (a–c)] cell lines.(*P
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 3

    The miR-30a-5p acted as an anti-oncogene. The relative expression level of miR-30a-5p was significantly downregulated by the miR-30a-5p inhibitor and increased by miR-30a-5p mimics (A). We detected cell proliferation after miR-30a-5p inhibitor and miR-30a-5p mimic transfection [B (a-c)] in renal carcinomas cells. Representative images of EdU assays and the relative fold changes of EdU positive cells were detected by the miR-30a-5p inhibitor and miR-30a-5p mimics [C (a–c)]. The relative cell migration was inhibited or accelerated after miR-30a-5p mimics or inhibitor transfection in renal cancer [D (a–c)] cell lines. Flow cytometry analysis was used to measured apoptotic cells after miR-30a-5p mimics or inhibitor transfection in the renal cancer [E (a–c)] cell lines.(*P < 0.05; **P < 0.01).

  • HIF1A-AS2 was a target of miR-30a-5p. The relative expression of miR-30a-5p was increased by si-HIF1A-AS2 (A). Dual-luciferase reporter assays were performed in 786-O and OS-RC-2 cells co-transfected with HIF1A-AS2-Wt or HIF1A-AS2-Mut and miR-30a-5p mimics or normal control (NC) (B). We detected cell proliferation after co-transfection with si-NC+NC in both renal carcinoma cell lines, si-HIF1A-AS2+miR-30a-5p inhibitor or si-HIF1A-AS2+miR-30a-5p mimics by CCK-8 and Edu assays (C-F). The relative cell migration after co-transfection with si-NC+NC, si-HIF1A-AS2+miR-30a-5p inhibitor or si-HIF1A-AS2+miR-30a-5p mimics, and the representative images are shown (G and H). The apoptotic cells were measured by flow cytometry analysis after co-transfection with si-NC+NC, si-HIF1A-AS2+miR-30a-5p inhibitor or si-HIF1A-AS2+miR-30a-5p mimics (I and J). (*P
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 4

    HIF1A-AS2 was a target of miR-30a-5p. The relative expression of miR-30a-5p was increased by si-HIF1A-AS2 (A). Dual-luciferase reporter assays were performed in 786-O and OS-RC-2 cells co-transfected with HIF1A-AS2-Wt or HIF1A-AS2-Mut and miR-30a-5p mimics or normal control (NC) (B). We detected cell proliferation after co-transfection with si-NC+NC in both renal carcinoma cell lines, si-HIF1A-AS2+miR-30a-5p inhibitor or si-HIF1A-AS2+miR-30a-5p mimics by CCK-8 and Edu assays (C-F). The relative cell migration after co-transfection with si-NC+NC, si-HIF1A-AS2+miR-30a-5p inhibitor or si-HIF1A-AS2+miR-30a-5p mimics, and the representative images are shown (G and H). The apoptotic cells were measured by flow cytometry analysis after co-transfection with si-NC+NC, si-HIF1A-AS2+miR-30a-5p inhibitor or si-HIF1A-AS2+miR-30a-5p mimics (I and J). (*P < 0.05; **P < 0.01).

  • HIF1A-AS2 positively regulates SOX4 expression via sponging miR-30a-5p. SOX4-Wt and miR-30a-5p mimics co-transfection inhibited luciferase activity (A) as shown using the dual-luciferase reporter assay. The relative expression level of SOX4 was decreased by si-HIF1A-AS2 (B). The relative expression level of SOX4 was regulated by miR-30a-5p mimics and inhibition (C). Overexpressing miR-30a-5p downregulated SOX4 expression and knockdown of miR-30a-5p upregulated SOX4 expression in renal carcinomas cells (D). Overexpression of HIF1A-AS2 upregulated SOX4 expression in 293T cells (E). Knockdown of HIF1A-AS2 downregulated SOX4 expression in renal carcinomas cells (F). Knockdown of HIF1A-AS2 downregulated transcriptional activity of the Wnt/β-catenin pathway as determined by the TOP flash/FOP flash reporter luciferase activity assay (G). CCK-8 assay (H), migration (I), flow cytometric analysis (J), Western blot and qPCR (K) showed that IWR-1 inhibited and even reversed the effect of pcDNA3.1-HIF1A-AS2 on cell progression in 786-O cells. Knockdown of SOX4 downregulated β-catenin expression in renal carcinomas cells (M). Knockdown of SOX4 reversed malignant phenotypic promotion of renal carcinomas cells induced by HIF1A-AS2. Si-SOX4 reversed SOX4 expression promotion induced by overexpression of HIF1A-AS2 in renal carcinomas cells (N). The relative expression level of SOX4 was decreased by si-SOX4 (L). (*P
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 5

    HIF1A-AS2 positively regulates SOX4 expression via sponging miR-30a-5p. SOX4-Wt and miR-30a-5p mimics co-transfection inhibited luciferase activity (A) as shown using the dual-luciferase reporter assay. The relative expression level of SOX4 was decreased by si-HIF1A-AS2 (B). The relative expression level of SOX4 was regulated by miR-30a-5p mimics and inhibition (C). Overexpressing miR-30a-5p downregulated SOX4 expression and knockdown of miR-30a-5p upregulated SOX4 expression in renal carcinomas cells (D). Overexpression of HIF1A-AS2 upregulated SOX4 expression in 293T cells (E). Knockdown of HIF1A-AS2 downregulated SOX4 expression in renal carcinomas cells (F). Knockdown of HIF1A-AS2 downregulated transcriptional activity of the Wnt/β-catenin pathway as determined by the TOP flash/FOP flash reporter luciferase activity assay (G). CCK-8 assay (H), migration (I), flow cytometric analysis (J), Western blot and qPCR (K) showed that IWR-1 inhibited and even reversed the effect of pcDNA3.1-HIF1A-AS2 on cell progression in 786-O cells. Knockdown of SOX4 downregulated β-catenin expression in renal carcinomas cells (M). Knockdown of SOX4 reversed malignant phenotypic promotion of renal carcinomas cells induced by HIF1A-AS2. Si-SOX4 reversed SOX4 expression promotion induced by overexpression of HIF1A-AS2 in renal carcinomas cells (N). The relative expression level of SOX4 was decreased by si-SOX4 (L). (*P < 0.05; **P < 0.01).

  • HIF1A-AS2 positively regulates SOX4 expression via sponging miR-30a-5p. Knockdown SOX4 reversed cell proliferation promotion induced by overexpression of HIF1A-AS2 (EdU, A and B; CCK8, C and D). Knockdown of SOX4 reversed cell migration promotion induced by overexpression of HIF1A-AS2 (E and F). Knockdown SOX4 reversed cell apoptosis inhibition induced by overexpression of HIF1A-AS2 (G and H). (*P
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 6

    HIF1A-AS2 positively regulates SOX4 expression via sponging miR-30a-5p. Knockdown SOX4 reversed cell proliferation promotion induced by overexpression of HIF1A-AS2 (EdU, A and B; CCK8, C and D). Knockdown of SOX4 reversed cell migration promotion induced by overexpression of HIF1A-AS2 (E and F). Knockdown SOX4 reversed cell apoptosis inhibition induced by overexpression of HIF1A-AS2 (G and H). (*P < 0.05; **P < 0.01).

  • The HIF1A-AS2 effect on renal carcinoma cell tumorigenicity. Tumors collected from mice are shown (A). The relative expression level of HIF1A-AS2 was decreased by LV-HIF1A-AS2 (B). Knockdown of HIF1A-AS2 downregulated SOX4. (C). The tumor weights of LV-HIF1A-AS2 or LV-NC treatment groups were measured and analyzed (D). We measured and analyzed the tumor volumes of the LV-HIF1A-AS2 or LV-NC treatment groups (E). Knockdown of HIF1A-AS2 downregulated SOX4 expression in renal cancer tissue and in vivo renal carcinoma cells [F(a and b)]. The schematic diagram of the oncogenic role of HIF1A-AS2 in renal carcinoma cells (G). HIF1A-AS2 functions as a miRNA sponge to positively regulate SOX4 expression by sponging miR-30a-5p and subsequently promoting malignant phenotypes of renal carcinoma cells, thus playing an oncogenic role in renal carcinomas pathogenesis.(*P
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 7

    The HIF1A-AS2 effect on renal carcinoma cell tumorigenicity. Tumors collected from mice are shown (A). The relative expression level of HIF1A-AS2 was decreased by LV-HIF1A-AS2 (B). Knockdown of HIF1A-AS2 downregulated SOX4. (C). The tumor weights of LV-HIF1A-AS2 or LV-NC treatment groups were measured and analyzed (D). We measured and analyzed the tumor volumes of the LV-HIF1A-AS2 or LV-NC treatment groups (E). Knockdown of HIF1A-AS2 downregulated SOX4 expression in renal cancer tissue and in vivo renal carcinoma cells [F(a and b)]. The schematic diagram of the oncogenic role of HIF1A-AS2 in renal carcinoma cells (G). HIF1A-AS2 functions as a miRNA sponge to positively regulate SOX4 expression by sponging miR-30a-5p and subsequently promoting malignant phenotypes of renal carcinoma cells, thus playing an oncogenic role in renal carcinomas pathogenesis.(*P < 0.05; **P < 0.01).

Tables

  • Figures
  • Supplementary Materials
    • View popup
    Table 1

    Correlation between HIF1A-AS2 expression and clinicopathological characteristics of renal cell cancer patients (clear cell renal cell carcinomas)

    CharacteristicsTotalExpression of HIF1A-AS2P
    Higher, n = 58Lower, n = 25
    Gender0.326
     Male5138 (74.5%)13 (25.5%)
     Female3220 (62.5%)12 (37.5%)
    Age (years)0.456
     ≤ 502818 (64.3%)10 (35.7%)
     > 505540 (72.7%)15 (27.3%)
    Tumor size (cm)0.027*
     ≤ 73117 (54.8%)14 (45.2%)
     > 75241 (78.8%)11 (21.2%)
    Differentiation0.007**
     Moderate/poor4940 (81.6%)9 (18.4%)
     Well3418 (52.9%)16 (47.1%)
    TNM stage0.007**
     T0-13116 (51.6%)15 (48.4%)
     T2-45242 (80.8%)10 (19.2%)
    Lymph node metastasis0.548
     N06748 (71.6%)19 (28.4%)
     N1 or above1610 (62.50%)6 (37.5%)

    *P < 0.05; **P < 0.01. Tumor node metastasis according to staging TNM of the American Joint Committee on Cancer in 2010.

    Supplementary Materials

    • Figures
    • Tables
    • [cbm-18-587-s001.pdf]
    PreviousNext
    Back to top

    In this issue

    Cancer Biology and Medicine: 18 (2)
    Cancer Biology & Medicine
    Vol. 18, Issue 2
    1 May 2021
    • Table of Contents
    • Index by author
    Print
    Download PDF
    Email Article

    Thank you for your interest in spreading the word on Cancer Biology & Medicine.

    NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

    Enter multiple addresses on separate lines or separate them with commas.
    LncRNA HIF1A-AS2 accelerates malignant phenotypes of renal carcinoma by modulating miR-30a-5p/SOX4 axis as a ceRNA
    (Your Name) has sent you a message from Cancer Biology & Medicine
    (Your Name) thought you would like to see the Cancer Biology & Medicine web site.
    Citation Tools
    LncRNA HIF1A-AS2 accelerates malignant phenotypes of renal carcinoma by modulating miR-30a-5p/SOX4 axis as a ceRNA
    Mingwei Chen, Xuedong Wei, Xiu Shi, Le Lu, Guangbo Zhang, Yuhua Huang, Jianquan Hou
    Cancer Biology & Medicine May 2021, 18 (2) 587-603; DOI: 10.20892/j.issn.2095-3941.2020.0209

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    Share
    LncRNA HIF1A-AS2 accelerates malignant phenotypes of renal carcinoma by modulating miR-30a-5p/SOX4 axis as a ceRNA
    Mingwei Chen, Xuedong Wei, Xiu Shi, Le Lu, Guangbo Zhang, Yuhua Huang, Jianquan Hou
    Cancer Biology & Medicine May 2021, 18 (2) 587-603; DOI: 10.20892/j.issn.2095-3941.2020.0209
    Twitter logo Facebook logo Mendeley logo
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Jump to section

    • Article
      • Abstract
      • Introduction
      • Materials and methods
      • Results
      • Discussion
      • Conclusions
      • Supporting Information
      • Grant support
      • Footnotes
      • References
    • Figures & Data
    • Info & Metrics
    • References
    • PDF

    Related Articles

    • No related articles found.
    • Google Scholar

    Cited By...

    • MiR-378a-3p acts as a tumor suppressor in gastric cancer via directly targeting RAB31 and inhibiting the Hedgehog pathway proteins GLI1/2
    • Google Scholar

    More in this TOC Section

    • Efbemalenograstim alfa as prophylaxis for chemotherapy-induced neutropenia in patients with non–small-cell lung cancer: a randomized, multicenter, phase II trial
    • Mitochondrial uncoupling inhibits serine catabolism via FTO activation in metastatic breast cancer
    • FDX1 expression promotes DSF/Cu-induced cuproptosis in gastric cancer cells
    Show more Original Article

    Similar Articles

    Keywords

    • HIF1A-AS2
    • SOX4
    • miR-30a-5p
    • kidney carcinoma
    • CeRNA

    Navigate

    • Home
    • Current Issue

    More Information

    • About CBM
    • About CACA
    • About TMUCIH
    • Editorial Board
    • Subscription

    For Authors

    • Instructions for authors
    • Journal Policies
    • Submit a Manuscript

    Journal Services

    • Email Alerts
    • Facebook
    • RSS Feeds
    • Twitter

     

    © 2026 Cancer Biology & Medicine

    Powered by HighWire